Prospective Phase II Study of Concurrent Radiotherapy Combined With Full-Course Immunotherapy or Consolidation Immunotherapy for Locally Advanced NSCLC

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a prospective, randomized phase II study evaluating concurrent chemoradiotherapy combined with full-course immunotherapy or consolidative immunotherapy in patients with unresectable, locally advanced non-small cell lung cancer.
Epistemonikos ID: 5e96da87561bf57e766b4f56dcb739536a5ba4af
First added on: Oct 15, 2026